171 related articles for article (PubMed ID: 20663910)
1. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.
Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T
Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910
[TBL] [Abstract][Full Text] [Related]
2. The E7 protein of the cottontail rabbit papillomavirus immortalizes normal rabbit keratinocytes and reduces pRb levels, while E6 cooperates in immortalization but neither degrades p53 nor binds E6AP.
Ganzenmueller T; Matthaei M; Muench P; Scheible M; Iftner A; Hiller T; Leiprecht N; Probst S; Stubenrauch F; Iftner T
Virology; 2008 Mar; 372(2):313-24. PubMed ID: 18067942
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
4. Association of cottontail rabbit papillomavirus E6 oncoproteins with the hDlg/SAP97 tumor suppressor.
Du M; Fan X; Hanada T; Gao H; Lutchman M; Brandsma JL; Chishti AH; Chen JJ
J Cell Biochem; 2005 Apr; 94(5):1038-45. PubMed ID: 15669058
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification.
Hiller T; Poppelreuther S; Stubenrauch F; Iftner T
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1262-7. PubMed ID: 16835321
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation.
Thomas M; Matlashewski G; Pim D; Banks L
Oncogene; 1996 Jul; 13(2):265-73. PubMed ID: 8710365
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
8. The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis.
Stöppler H; Stöppler MC; Johnson E; Simbulan-Rosenthal CM; Smulson ME; Iyer S; Rosenthal DS; Schlegel R
Oncogene; 1998 Sep; 17(10):1207-14. PubMed ID: 9771963
[TBL] [Abstract][Full Text] [Related]
9. A plant lignan, 3'-O-methyl-nordihydroguaiaretic acid, suppresses papillomavirus E6 protein function, stabilizes p53 protein, and induces apoptosis in cervical tumor cells.
Allen KL; Tschantz DR; Awad KS; Lynch WP; DeLucia AL
Mol Carcinog; 2007 Jul; 46(7):564-75. PubMed ID: 17393435
[TBL] [Abstract][Full Text] [Related]
10. Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis.
Aguilar-Lemarroy A; Gariglio P; Whitaker NJ; Eichhorst ST; zur Hausen H; Krammer PH; Rösl F
Oncogene; 2002 Jan; 21(2):165-75. PubMed ID: 11803460
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Hebner C; Beglin M; Laimins LA
J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
[TBL] [Abstract][Full Text] [Related]
12. The domain of p53 required for binding HPV 16 E6 is separable from the degradation domain.
Mansur CP; Marcus B; Dalal S; Androphy EJ
Oncogene; 1995 Feb; 10(3):457-65. PubMed ID: 7845670
[TBL] [Abstract][Full Text] [Related]
13. Lack of correlation between p53 protein level and sensitivity of DNA-damaging agents in keratinocytes carrying adenovirus E1a mutants.
Sanchez-Prieto R; Lleonart M; Ramón y Cajal S
Oncogene; 1995 Aug; 11(4):675-82. PubMed ID: 7651731
[TBL] [Abstract][Full Text] [Related]
14. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
15. Differential p53-mediated responses to solar-simulated radiation in human papillomavirus type 16-infected keratinocytes.
Mouret S; Favier A; Beani JC; Leccia MT
Exp Dermatol; 2007 Jun; 16(6):476-84. PubMed ID: 17518987
[TBL] [Abstract][Full Text] [Related]
16. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy.
Liu Y; Heilman SA; Illanes D; Sluder G; Chen JJ
Cancer Res; 2007 Mar; 67(6):2603-10. PubMed ID: 17363579
[TBL] [Abstract][Full Text] [Related]
17. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
18. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of serum- and calcium-induced terminal differentiation of human keratinocytes by HPV 16 E6: study of the association with p53 degradation, inhibition of p53 transactivation, and binding to E6BP.
Sherman L; Itzhaki H; Jackman A; Chen JJ; Koval D; Schlegel R
Virology; 2002 Jan; 292(2):309-20. PubMed ID: 11878933
[TBL] [Abstract][Full Text] [Related]
20. Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.
Asadurian Y; Kurilin H; Lichtig H; Jackman A; Gonen P; Tommasino M; Zehbe I; Sherman L
J Med Virol; 2007 Nov; 79(11):1751-60. PubMed ID: 17854024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
